英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Ginsenoside Ra3 |
人參皂苷RA3 |
90985-77-6 |
詳細(xì)
|
Ganoderic acid F |
靈芝酸 F |
98665-15-7 |
詳細(xì)
|
GSK-3 inhibitor 1 |
3-(9-氟-1,2,3,4-四氫吡咯并[3,2,1-JK][1,4]苯并二氮雜卓-7-基)-4-咪唑并[1,2-A]吡啶-3-基-1H-吡咯-2,5-二酮單鹽酸鹽 |
603272-51-1 |
詳細(xì)
|
Guaiacin |
愈創(chuàng)木素 |
36531-08-5 |
詳細(xì)
|
GDP-α-D-mannose disodium |
鳥苷 5'-(三氫二磷酸酯) P'-ALPHA-D-甘露糖基酯二鈉鹽 |
148296-46-2 |
詳細(xì)
|
GDC-0276 |
GDC0276 |
1494581-70-2 |
詳細(xì)
|
Gamitrinib TPP hexafluorophosphate |
1131626-47-5 |
1131626-47-5 |
詳細(xì)
|
GSK2593074A |
GSK2593074A |
1337531-06-2 |
詳細(xì)
|
GSK598809 |
GSK598809 |
863680-45-9 |
詳細(xì)
|
GSK-3β inhibitor 1 |
2H-Indol-2-one, 1,3-dihydro-3-(2-pyridinylmethylene)-, (3Z)- |
187325-53-7 |
詳細(xì)
|
Givosiran |
吉沃西蘭 |
1639325-43-1 |
詳細(xì)
|
Galidesivir hydrochloride |
(2S,3S,4R,5R)-2-(4-氨基-5H-吡咯并[3,2-D]嘧啶-7-基)-5-(羥基甲基)-3,4-吡咯烷二醇單鹽酸鹽 |
222631-44-9 |
詳細(xì)
|
Glucocorticoid receptor agonist-2 |
|
2166378-92-1 |
詳細(xì)
|
GSK-269984A |
892664-04-9 |
892664-04-9 |
詳細(xì)
|
GPR40 Activator 2 |
化合物 T11457 |
1312787-30-6 |
詳細(xì)
|
Ginsenoside Rh8 |
人參皂苷RH8 |
343780-69-8 |
詳細(xì)
|
GDC-0425 |
5-((1-乙基哌啶-4-基)氧基)-9H-吡咯并[2,3-B:5,4-C']二吡啶-6-甲腈 |
1200129-48-1 |
詳細(xì)
|
Ganolactone A |
GANOLACTONE A |
173268-82-1 |
詳細(xì)
|
GLP-26 |
GLP-26 |
2133017-36-2 |
詳細(xì)
|
GNE-0946 |
GNE-0946 |
1677667-24-1 |
詳細(xì)
|
G12 |
G12 |
162550-82-5 |
詳細(xì)
|
gamma-secretase modulator 1 hydrochloride |
化合物 GAMMA-SECRETASE MODULATOR 1 HYDROCHLORIDE |
2741571-83-3 |
詳細(xì)
|
Gumelutamide |
化合物 GUMELUTAMIDE |
1831085-48-3 |
詳細(xì)
|
Gomisin G |
戈米辛G |
62956-48-3 |
詳細(xì)
|
20(R)-Ginsenoside Rg2 |
(R型)人參皂苷Rg2 |
80952-72-3 |
詳細(xì)
|
Ginsenoside Rk2 |
人參皂苷RK2 |
364779-14-6 |
詳細(xì)
|
GSK256066 Trifluoroacetate |
GSK256066 三氟乙酸鹽 |
1415560-64-3 |
詳細(xì)
|
Gigantol |
石斛酚 |
67884-30-4 |
詳細(xì)
|
20-gluco-ginsenoside Rf |
20-葡萄糖人參皂苷R |
68406-27-9 |
詳細(xì)
|
GSK-3685032 |
GSK 3685032 |
2170137-61-6 |
詳細(xì)
|
Glycolithocholic acid 3-sulfate |
甘膽酸硫酸鹽 |
15324-64-8 |
詳細(xì)
|
Gelsenicine |
葫蔓藤堿甲 |
82354-38-9 |
詳細(xì)
|
Ginsenoside Rs1 |
人參皂苷 RS1 |
87733-67-3 |
詳細(xì)
|
GW-406381 |
GW-406381 |
221148-46-5 |
詳細(xì)
|
Glabranine |
GLABRANIN |
41983-91-9 |
詳細(xì)
|
Glucocorticoid receptor agonist |
ALPHA-[2-(5-氟-2-羥基苯基)-2-甲基丙基]-ALPHA-(三氟甲基)-(ALPHAR)-1H-吡咯并[2,3-C]吡啶-2-乙醇 |
1245526-82-2 |
詳細(xì)
|
GPR120 Agonist 3 |
1599477-75-4 |
1599477-75-4 |
詳細(xì)
|
Glicoricone |
甘草瑞酮 |
161099-37-2 |
詳細(xì)
|
GSK2245035 |
GSK2245035 |
1207629-49-9 |
詳細(xì)
|
GB1107 |
GB1107 |
1978336-61-6 |
詳細(xì)
|
GLP-1R modulator L7-028 |
化合物GLP-1R MODULATOR L7-028 |
2648317-95-5 |
詳細(xì)
|
Ginsenoside Ra1 |
人參皂苷RA1 |
83459-41-0 |
詳細(xì)
|
Glycolic acid-d2 |
乙醇酸-2,2-[D2] |
75502-10-2 |
詳細(xì)
|
GSK3-IN-3 |
化合物GSK3-IN-3 |
331963-27-0 |
詳細(xì)
|
GN25 |
GN25 |
1227401-27-5 |
詳細(xì)
|
GPR40 Activator 1 |
1309435-60-6 |
1309435-60-6 |
詳細(xì)
|
Glycoside O-4 |
麥冬皂苷B單硫酸酯 |
94898-61-0 |
詳細(xì)
|
Ginsenoside F5 |
人參皂苷F5 |
189513-26-6 |
詳細(xì)
|
GNA002 |
GNA002 |
1385035-79-9 |
詳細(xì)
|
GNE-6468 |
化合物 T15404 |
1677668-27-7 |
詳細(xì)
|
Galantamine Hydrobromide Lycoremine |
氫溴酸加蘭他敏 |
510-77-0 |
詳細(xì)
|
Ginsenoside Ra6 |
Ginsenoside Ra6 |
1346522-89-1 |
詳細(xì)
|
GnRH antagonist 2 |
GNRH ANTAGONIST 2 |
1709823-61-9 |
詳細(xì)
|
Gelsevirine |
鉤吻綠堿 |
38990-03-3 |
詳細(xì)
|
GRGDSP |
GRGDSP |
91037-75-1 |
詳細(xì)
|
Ganodermanontriol |
靈芝馬酮 |
106518-63-2 |
詳細(xì)
|
Ganoderenic acid D |
靈芝烯酸D |
100665-43-8 |
詳細(xì)
|
Ginsenoside Rd2 |
人參皂苷 RD2 |
83480-64-2 |
詳細(xì)
|
(-)Gomisin L1 |
(-)戈米辛L1 |
82425-43-2 |
詳細(xì)
|
Gensenoside Rh7 |
人參皂苷 RH7 |
343780-68-7 |
詳細(xì)
|
GSK3368715 dihydrochloride |
GSK3368715 DIHYDROCHLORIDE |
1628925-77-8 |
詳細(xì)
|
Gartanin |
1,3,5,8-四羥基-2,4-雙(3-甲基-2-丁烯基)-9H-氧雜蒽-9-酮 |
33390-42-0 |
詳細(xì)
|
Garsorasib |
GARSORASIB |
2559761-14-5 |
詳細(xì)
|
(E/Z)-GSK-3β inhibitor 1 |
3-(吡啶-2-基亞甲基)吲哚啉-2-酮 |
3367-88-2 |
詳細(xì)
|
Glucosylceramide synthase-IN-2 |
化合物 GLUCOSYLCERAMIDE SYNTHASE-IN-2 |
2597958-02-4 |
詳細(xì)
|
Ginsenoside Rs2 |
人參皂苷 RS2 |
87733-66-2 |
詳細(xì)
|
Gefitinib impurity 2 |
吉非替尼雜質(zhì) |
246512-44-7 |
詳細(xì)
|
Ganoderenic acid E |
靈芝烯酸E |
110241-23-1 |
詳細(xì)
|
GW768505A free base |
GW768505A |
501693-25-0 |
詳細(xì)
|
GNE-0439 |
GNE0439 |
1241902-40-8 |
詳細(xì)
|
Glucose dehydrogenase (GDH) |
葡萄糖脫氫酶 |
9028-53-9 |
詳細(xì)
|
GSK 690 Hydrochloride |
化合物 GSK 690 HYDROCHLORIDE |
2436760-79-9 |
詳細(xì)
|
Ginsenoside Ra2 |
人參皂苷RA2 |
83459-42-1 |
詳細(xì)
|
Ganoderic acid G |
靈芝酸 G |
98665-22-6 |
詳細(xì)
|
Garcinone D |
GARCINONE D |
107390-08-9 |
詳細(xì)
|
GSK-A1 |
GSK-A1 |
1416334-69-4 |
詳細(xì)
|
GDC-0575 dihydrochloride |
1657014-42-0 |
1657014-42-0 |
詳細(xì)
|
8-Geranyl daidzein |
8-香葉草基大豆苷元 |
1072940-16-9 |
詳細(xì)
|
GNE 220 hydrochloride |
GNE 220 Hydrochloride |
2448286-21-1 |
詳細(xì)
|
Glutaminase-IN-1 |
GLUTAMINASE-IN-1 |
2247127-79-1 |
詳細(xì)
|
Galegine hydrochloride |
1-(3-甲基丁-2-烯-1-基)鹽酸胍 |
2368870-39-5 |
詳細(xì)
|
GSK-3/CDK5/CDK2-IN-1 |
GSK-3/CDK5/CDK2-IN-1 |
395074-72-3 |
詳細(xì)
|
GSK3494245 |
化合物 GSK3494245 |
2080410-41-7 |
詳細(xì)
|
Glabrol |
光甘草酚 |
59870-65-4 |
詳細(xì)
|
GDC-0834 S-enantiomer |
化合物 T11378 |
1133432-50-4 |
詳細(xì)
|
GNE-7915 tosylate |
5MG |
2070015-00-6 |
詳細(xì)
|
GSK8573 |
GSK8573 |
1693766-04-9 |
詳細(xì)
|
Giredestrant |
GDC-9545 |
1953133-47-5 |
詳細(xì)
|
Glucocorticoid receptor agonist-2 Ala-Ala-Mal |
化合物 GLUCOCORTICOID RECEPTOR AGONIST-2 ALA-ALA-MAL |
2166376-64-1 |
詳細(xì)
|
GSK1820795A |
|
2650253-86-2 |
詳細(xì)
|
GalNac-L96 |
L96.TEA |
1159408-62-4 |
詳細(xì)
|
Ginsenoside Rh4 |
人參皂苷 RH4 |
174721-08-5 |
詳細(xì)
|
(+)Gomisin M2 |
五味子脂素 M2 |
82425-45-4 |
詳細(xì)
|
GSK726701A |
GSK726701A |
945721-87-9 |
詳細(xì)
|
GLPG2938 |
GLPG2938 |
2130996-00-6 |
詳細(xì)
|
GSM-1 |
4-Piperidineacetic acid, 1-[(1R)-1-(4-chlorophenyl)-4-methylpentyl]-2-[4-(trifluoromethyl)phenyl]-, (2S,4R)- |
884600-68-4 |
詳細(xì)
|
Glyco-diosgenin |
糖酵素(GDN) |
1402423-29-3 |
詳細(xì)
|
Gelucire 44/14 |
月桂酸聚乙二醇甘油酯 |
121548-04-7 |
詳細(xì)
|
GSK-872 hydrochloride |
化合物GSK872 HCL |
2703752-81-0 |
詳細(xì)
|
GNF-8625 monopyridin-N-piperazine hydrochloride |
化合物T40034 |
2412055-62-8 |
詳細(xì)
|